« Home

Home / Biosciences » Biochemistry » Biosciences » Molecular Biology » Elliott & Elliott: Biochemistry and Molecular Biology 4e » Student resources » Hyperlinked bibliography » Chapter 14

Elliott & Elliott: Biochemistry and Molecular Biology 4e

Chapter 14

Please note that some of the sites you will be directed to from this page may require a username and password to access the article.

Fatty acid synthase

Smith, S. (1994). The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J., 8, 1248-59.
Illustrated article on the structure and function of this remarkable protein.

Membrane lipid synthesis

Dawidowicz, E. A. (1987). Dynamics of membrane lipid metabolism and turnover. Annu. Rev. Biochem., 56, 43-61 [DOI: 10.1146/annurev.bi.56.070187.000355].
Review on membrane lipids, their site of synthesis, transport, and assembly into membranes.

Rooney, S. A., Young, S. L., and Mendelson, C. R. (1994). Molecular and cellular processing of lung surfactant. FASEB J., 8, 957-67.
Reviews a more physiological role of phospholipid - that of lining the alveoli.

Kent, C. (1995). Eukaryotic phospholipid biosynthesis. Annu. Rev. Biochem., 64, 315-43 [DOI: 10.1146/annurev.bi.64.070195.001531].
An account of the various pathways for the synthesis of the membrane phospholipids.

Kent, C. and Carman, G. M. (1999). Interactions among pathways for phosphatidylcholine metabolism, CTP synthesis and secretion through the Golgi apparatus. Trends Biochem. Sci., 24, 146-50 [DOI: 10.1016/S0968-0004(99)01365-1].
Prostaglandins, thromboxanes, and cyclooxygenases

Evans, J. F. and Kargman, S. L. (2004). Cancer and cyclooxygenase-2 (COX-2) inhibition. Curr. Pharm. Des., 10, 627-34 [DOI: 10.2174/1381612043453126].

Foral, P. A., et al. (2003). Gastrointestinal-related adverse effects of COX-2 inhibitors. Drugs Today, 39, 939-48 [DOI: 10.1358/dot.2003.39.12.799412].

Fitzpatrick, F. A. (2004). Cyclooxygenase enzymes: regulation and function. Curr. Pharm. Des., 10, 577-88 [DOI: 10.2174/1381612043453144].

Garaj, N. M. (2003). Cyclooxygenase-2 inhibitors. Anesth. Analg., 96, 1720-38 [DOI: 10.1213/01.ANE.0000061461.55712.C5].

Ramalingam, S. and Belani, C. P. (2004). Cyclooxygenase-2 inhibitors in lung cancer. Clin. Lung Cancer, 5, 245-33 [DOI: 10.3816/CLC.2004.n.006].

Wong, D., Wang, M., Cheng, Y., and FitzGerald, G. A. (2005). Cardiovascular hazard and non-steroidal anti-inflammatory drugs. Current Opinion in Pharmacol., 5, 204-10 [DOI: 10.1016/j.coph.2005.02.001].

Smith, W. L. (2008). Nutritionally essential fatty acids and biologically indispensable cyclooxygenases. Trends Biochem. Sci., 33, 27-37 [DOI: 10.1016/j.tibs.2007.09.013].